# A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors

> **NCT03734926** · PHASE1 · UNKNOWN · sponsor: **Guangdong Zhongsheng Pharmaceutical Co., Ltd.** · enrollment: 90 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Gastric Cancer
- Esophageal Cancer
- Colorectal Cancer

## Interventions

- **DRUG:** ZSP1241

## Key facts

- **NCT ID:** NCT03734926
- **Lead sponsor:** Guangdong Zhongsheng Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-13
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734926, "A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03734926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*